Position in BHVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,446,822
-$2,578,418 QoQ
Shares Held
164,437
-72.3% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#84
of 294 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SPHERA FUNDS MANAGEMENT LTD. holds $446,002,188 across 71 Biotechnology names. BHVN ranks #56 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MLYS |
Mineralys Therapeutics, Inc.
|
1,469,971 | $39,659,817 | |
| 2 | SNDX |
Syndax Pharmaceuticals Inc
|
1,014,606 | $22,179,287 | |
| 3 | RARE |
Ultragenyx Pharmaceutical Inc.
|
588,494 | $19,649,814 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
328,550 | $18,799,631 | |
| 5 | CYTK |
Cytokinetics Inc
|
219,987 | $18,740,692 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
245,346 | $18,273,370 | |
| 7 | COGT |
Cogent Biosciences, Inc.
|
459,340 | $17,776,458 | |
| 8 | INSM |
INSMED Inc
|
118,800 | $12,666,456 |
All Filings in BHVN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,446,822 | 164,437 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,025,240 | 594,000 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 | $1,368,236 | 91,155 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,051,198 | 145,372 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,398,807 | 99,784 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $5,845,050 | 156,494 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,662,150 | 133,323 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||